RSF1 functions as an oncogene in osteosarcoma and is regulated by XIST/miR-193a-3p axis - PubMed (original) (raw)
RSF1 functions as an oncogene in osteosarcoma and is regulated by XIST/miR-193a-3p axis
Dapeng Wu et al. Biomed Pharmacother. 2017 Nov.
Abstract
RSF1 (HBXAP), is a member of ATP-dependent chromatin remodeling factor. Dysregulated RSF1 has been reported to be related to tumor progression. However, the function of RSF1 in osteosarcoma (OS) remains unclear. In this study, we showed that RSF1 expression was upregulated in OS cells. RSF1 inhibition suppressed OS cell proliferation and invasion. We further showed that MAPK/Erk signaling pathway was inactivated by RSF1 suppression. In addition, RSF1 was identified as a direct target of miR-193a-3p. Clinically, RSF1 was increased and associated with advanced clinical features and poor overall survival of OS patients. MiR-193a-3p expression was decreased and associated with advanced clinical features and poor overall survival of OS patients. In addition, we found that miR-193a-3p was negatively correlated with RSF1 expression in OS tissues. Moreover, our data showed that XIST could function as competing endogenous RNA to repress miR-193a-3p, which regulated its downstream target RSF1. In conclusion, our findings demonstrated that the XIST/miR-193a-3p/RSF1 axis might contribute to the progression and act as a therapeutic target of OS patients.
Keywords: MAPK/Erk; Osteosarcoma; RSF1; XIST; miR-193a-3p.
Copyright © 2017 Elsevier Masson SAS. All rights reserved.
Similar articles
- LncRNA TUG1 promotes cell proliferation and suppresses apoptosis in osteosarcoma by regulating miR-212-3p/FOXA1 axis.
Xie C, Chen B, Wu B, Guo J, Cao Y. Xie C, et al. Biomed Pharmacother. 2018 Jan;97:1645-1653. doi: 10.1016/j.biopha.2017.12.004. Epub 2017 Dec 8. Biomed Pharmacother. 2018. PMID: 29793327 - KIAA1429 promotes osteosarcoma progression by promoting stem cell properties and is regulated by miR-143-3p.
Han Q, Yang J, Yang H, Li C, Li J, Cao Y. Han Q, et al. Cell Cycle. 2020 May;19(10):1172-1185. doi: 10.1080/15384101.2020.1749465. Epub 2020 Apr 14. Cell Cycle. 2020. PMID: 32286148 Free PMC article. Retracted. - Long noncoding RNA OIP5-AS1 mediates resistance to doxorubicin by regulating miR-137-3p/PTN axis in osteosarcoma.
Sun X, Tian C, Zhang H, Han K, Zhou M, Gan Z, Zhu H, Min D. Sun X, et al. Biomed Pharmacother. 2020 Aug;128:110201. doi: 10.1016/j.biopha.2020.110201. Epub 2020 May 24. Biomed Pharmacother. 2020. PMID: 32460190 - Biological Function of MicroRNA193a-3p in Health and Disease.
Grossi I, Salvi A, Abeni E, Marchina E, De Petro G. Grossi I, et al. Int J Genomics. 2017;2017:5913195. doi: 10.1155/2017/5913195. Epub 2017 Sep 5. Int J Genomics. 2017. PMID: 29038785 Free PMC article. Review. - Role of miR-193a in Cancer: Complexity and Factors Control the Pattern of its Expression.
Mamoori A, Gopalan V, Lam AK. Mamoori A, et al. Curr Cancer Drug Targets. 2018;18(7):618-628. doi: 10.2174/1568009618666180308105727. Curr Cancer Drug Targets. 2018. PMID: 29521232 Review.
Cited by
- Silencing of HuR Inhibits Osteosarcoma Cell Epithelial-Mesenchymal Transition via AGO2 in Association With Long Non-Coding RNA XIST.
Liu Y, Zhang Y, Zhang J, Ma J, Xu X, Wang Y, Zhou Z, Jiang D, Shen S, Ding Y, Zhou Y, Zhuang R. Liu Y, et al. Front Oncol. 2021 Mar 19;11:601982. doi: 10.3389/fonc.2021.601982. eCollection 2021. Front Oncol. 2021. PMID: 33816232 Free PMC article. - Anticancer Activity of Euplotin C, Isolated from the Marine Ciliate Euplotes crassus, Against Human Melanoma Cells.
Carpi S, Polini B, Poli G, Alcantara Barata G, Fogli S, Romanini A, Tuccinardi T, Guella G, Frontini FP, Nieri P, Di Giuseppe G. Carpi S, et al. Mar Drugs. 2018 May 16;16(5):166. doi: 10.3390/md16050166. Mar Drugs. 2018. PMID: 29772645 Free PMC article. - Osteosarcoma in a ceRNET perspective.
Mosca N, Alessio N, Di Paola A, Marrapodi MM, Galderisi U, Russo A, Rossi F, Potenza N. Mosca N, et al. J Biomed Sci. 2024 Jun 5;31(1):59. doi: 10.1186/s12929-024-01049-y. J Biomed Sci. 2024. PMID: 38835012 Free PMC article. Review. - miR-4295 promotes cell proliferation, migration and invasion of osteosarcoma through targeting interferon regulatory factor 1.
Cheng JP, Huang B, Duan JH, Yi KJ, Zhuang ZL. Cheng JP, et al. Oncol Lett. 2020 Nov;20(5):260. doi: 10.3892/ol.2020.12123. Epub 2020 Sep 18. Oncol Lett. 2020. PMID: 32989394 Free PMC article. - RSF1 in cancer: interactions and functions.
Cai G, Yang Q, Sun W. Cai G, et al. Cancer Cell Int. 2021 Jun 19;21(1):315. doi: 10.1186/s12935-021-02012-9. Cancer Cell Int. 2021. PMID: 34147108 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous